Mark E. Smith

3.0k total citations · 1 hit paper
73 papers, 2.3k citations indexed

About

Mark E. Smith is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine. According to data from OpenAlex, Mark E. Smith has authored 73 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Oncology, 22 papers in Pulmonary and Respiratory Medicine and 16 papers in Pathology and Forensic Medicine. Recurrent topics in Mark E. Smith's work include Sarcoma Diagnosis and Treatment (12 papers), Viral-associated cancers and disorders (10 papers) and Lymphoma Diagnosis and Treatment (9 papers). Mark E. Smith is often cited by papers focused on Sarcoma Diagnosis and Treatment (12 papers), Viral-associated cancers and disorders (10 papers) and Lymphoma Diagnosis and Treatment (9 papers). Mark E. Smith collaborates with scholars based in United Kingdom, United States and Tanzania. Mark E. Smith's co-authors include Walter F. Bodmer, I B Kerr, David P. Lane, Andrew Rowan, Julian Gannon, Nanda R. Rodrigues, Cyril Fisher, Sharon W. Weiss, Kathryn C. Zoon and Gerard Cowley and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Cancer.

In The Last Decade

Mark E. Smith

70 papers receiving 2.2k citations

Hit Papers

p53 mutations in colorectal cancer. 1990 2026 2002 2014 1990 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark E. Smith United Kingdom 22 1.1k 758 510 421 382 73 2.3k
Raymond Tubbs United States 28 936 0.8× 815 1.1× 352 0.7× 706 1.7× 375 1.0× 72 2.5k
Elizabeth Hyjek United States 29 1.8k 1.5× 1.1k 1.4× 671 1.3× 799 1.9× 356 0.9× 68 3.6k
Jean‐François Mosnier France 31 825 0.7× 917 1.2× 258 0.5× 716 1.7× 316 0.8× 124 3.4k
T G Pretlow United States 23 615 0.5× 1.1k 1.5× 249 0.5× 241 0.6× 554 1.5× 56 2.7k
Gerald Höfler Austria 24 945 0.8× 519 0.7× 756 1.5× 327 0.8× 280 0.7× 61 2.6k
Chihiro Shimazaki Japan 33 1.2k 1.1× 1.5k 1.9× 594 1.2× 659 1.6× 178 0.5× 213 4.0k
A. Schauer Germany 28 739 0.7× 1.0k 1.3× 309 0.6× 382 0.9× 356 0.9× 146 2.9k
Doina Ivan United States 31 1.7k 1.5× 719 0.9× 616 1.2× 325 0.8× 287 0.8× 136 3.1k
Aaron P. Rapoport United States 32 2.1k 1.8× 1.2k 1.6× 491 1.0× 703 1.7× 350 0.9× 162 3.8k
Heinz Sill Austria 32 912 0.8× 1.2k 1.6× 438 0.9× 271 0.6× 344 0.9× 137 3.3k

Countries citing papers authored by Mark E. Smith

Since Specialization
Citations

This map shows the geographic impact of Mark E. Smith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark E. Smith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark E. Smith more than expected).

Fields of papers citing papers by Mark E. Smith

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark E. Smith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark E. Smith. The network helps show where Mark E. Smith may publish in the future.

Co-authorship network of co-authors of Mark E. Smith

This figure shows the co-authorship network connecting the top 25 collaborators of Mark E. Smith. A scholar is included among the top collaborators of Mark E. Smith based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark E. Smith. Mark E. Smith is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Smith, Mark E., et al.. (2018). Local referral of pancreatectomy patients to improve surgical quality. HPB. 20. S22–S23. 1 indexed citations
2.
Hilton, David A., et al.. (2010). A meningeal myofibroblastic neoplasm related to solitary fibrous tumour and associated with a malignant neuroblastic element. Journal of Clinical Pathology. 63(2). 180–183. 2 indexed citations
3.
Glaysher, Sharon, Dennis Yiannakis, Francis G Gabriel, et al.. (2009). Resistance gene expression determines the in vitro chemosensitivity of non-small cell lung cancer (NSCLC). BMC Cancer. 9(1). 300–300. 33 indexed citations
4.
Christie, Lesley, Alan Evans, Susan E. Bray, et al.. (2005). Lesions resembling Langerhans cell histiocytosis in association with other lymphoproliferative disorders: a reactive or neoplastic phenomenon?. Human Pathology. 37(1). 32–39. 50 indexed citations
5.
Smith, Mark E., et al.. (2005). Evaluation of perineurial differentiation in epithelioid sarcoma. Histopathology. 47(6). 575–581. 21 indexed citations
6.
Smith, Mark E., et al.. (2004). Reversal of glandular polarity in the lymphovascular compartment of breast cancer. Journal of Clinical Pathology. 57(10). 1114–1117. 11 indexed citations
7.
Adams, Sharlene, et al.. (2003). Perianal Hodgkin's lymphoma complicating Crohn's disease. International Journal of Colorectal Disease. 18(2). 174–176. 6 indexed citations
8.
McCluggage, W. Glenn, Mark Catherwood, H. Denis Alexander, et al.. (2002). Immunohistochemical expression of CD10 and t(14;18) chromosomal translocation may be indicators of follicle centre cell origin in nodal diffuse large B‐cell lymphoma. Histopathology. 41(5). 414–420. 25 indexed citations
9.
Robertson, N J, et al.. (1999). A woman who bled after a decade of dyspnoea. Gut. 45(2). 310–310. 4 indexed citations
10.
Smith, Mark E., et al.. (1998). Epithelioid sarcoma: presence of vascular‐endothelial cadherin and lack of epithelial cadherin. Histopathology. 33(5). 425–431. 34 indexed citations
11.
Robertson, N J, J Rahamim, & Mark E. Smith. (1997). Carcinosarcoma of the oesophagus showing neuroendocrine, squamous and glandular differentiation. Histopathology. 31(3). 263–266. 15 indexed citations
12.
Moseley, R, et al.. (1997). AN IMMUNOCYTOCHEMICAL STUDY OF MHC CLASS I EXPRESSION ON HUMAN LANGERHANS CELLS AND MELANOCYTES. The Journal of Pathology. 181(4). 419–425. 11 indexed citations
13.
Smith, Mark E. & Massimo Pignatelli. (1997). The molecular histology of neoplasia: the role of the cadherin/catenin complex. Histopathology. 31(2). 107–111. 53 indexed citations
14.
Kakouri, Eleni, Jeremy Whelan, Stewart Coltart, Mark E. Smith, & Robert L. Souhami. (1997). Multi‐Focal, Multi‐Centric Angiosarcoma of Bone. Sarcoma. 1(3-4). 183–187. 5 indexed citations
15.
Ashton‐Key, Margaret, Gerard Cowley, & Mark E. Smith. (1996). Cadherins in reactive lymph nodes and lymphomas: high expression in anaplastic large cell lymphomas. Histopathology. 28(1). 55–59. 13 indexed citations
16.
Cowley, Gerard & Mark E. Smith. (1996). CADHERIN EXPRESSION IN MELANOCYTIC NAEVI AND MALIGNANT MELANOMAS. The Journal of Pathology. 179(2). 183–187. 36 indexed citations
17.
Deune, E. Gene, et al.. (1996). Prevention of Ischemia-Reperfusion Injury with a Synthetic Metalloprotein Superoxide Dismutase Mimic, SC52608. Plastic & Reconstructive Surgery. 98(4). 711–718. 12 indexed citations
18.
Cowley, Gerard & Mark E. Smith. (1995). Modulation of E‐cadherin expression and morphological phenotype in the intravascular component of adenocarcinomas. International Journal of Cancer. 60(3). 325–329. 38 indexed citations
19.
Smith, Mark E., C S Holgate, Claire O’Brien, et al.. (1987). Ploidy, proliferative activity, cluster differentiation antigen expression and clinical remission in highgrade non‐Hodgkin's lymphoma. Histopathology. 11(10). 1043–1054. 10 indexed citations
20.
Smith, Mark E., et al.. (1975). Enhancement and Interference in Chickens Inoculated with Marek's Disease Herpesvirus and Oncornaviruses. Experimental Biology and Medicine. 150(3). 574–577. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026